In Vitro Diagnostics (IVD) Market to Receive USD 164.99 Billion by 2029, Size, Shares, Trends, Future Demand, Growth Opportunities and Revenue Analysis

LONDON, Jan. 12, 2023 (GLOBE NEWSWIRE) — The comprehensive industry research on In Vitro Diagnostics (IVD) Market‘ published by Data Bridge Market research includes growth analysis, regional marketing, challenges, opportunities, and drivers analyzed in the report. The report carefully examines the global In Vitro Diagnostics (IVD) Market, with a focus on most of the major players and their business strategies, geographical scope, market segments, product landscape and price, and cost structure. In Vitro Diagnostics (IVD) market report encompasses different industry verticals for In Vitro Diagnostics (IVD) industry such as company profile, contact details of the manufacturer, product specifications, geographical scope, production value, market structures, recent developments, revenue analysis, market shares and possible sales volume of the company.

Data Bridge Market Research analyses that the In vitro diagnostics (IVD) market which was USD 111.67 billion in 2021, would rocket up to USD 164.99 billion by 2029, and is expected to undergo a CAGR of 5.00% during the forecast period 2022 to 2029.

Download the Exclusive Sample of In Vitro Diagnostics (IVD) Market Report in PDF Version @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-in-vitro-diagnostics-ivd-market

Market Overview: –

The tests used in in vitro diagnostics are carried out on a person’s blood or tissue sample. They assist in keeping a close eye on the patient’s health and are used to accurately test for and diagnose diseases or any underlying issues. These diagnostic procedures can assist in determining the optimal course of treatment for each individual.

Devices are used in specialised medical facilities to carry out diagnostics since the application and management of the IVD market require technical competence. To diagnose illnesses, disorders, and infections, in vitro diagnostics (IVD) refers to the reagents, tools, and software used to analyse specimens taken from the human body, such as blood, urine, stool, tissues, and other physiological fluids. Other IVD device types employ various techniques, including immunodiagnostics, tissue diagnostics, haematological, and molecular diagnostics.

Opportunities

The growth of the market is anticipated to be fuelled by the creation of automated IVD systems for labs and hospitals to give quick, precise, and error-free diagnosis. The market is expanding as a result of the increasing number of IVD products being introduced by major companies.

Some of the major players operating in the in vitro diagnostics (IVD) market are:

• Koninklijke Philips N.V. (Netherlands)

• CANON MEDICAL SYSTEMS CORPORATION (Japan)

• FUJIFILM Holdings Corporation (Japan)

• Konica Minolta Business Solutions India Private Limited (Japan)

• TOSHIBA CORPORATION (Japan)

• Sanrad Medical Systems Private Limited (India)

• ONEX Corporation (Canada)

• Shimadzu Corporation (Japan)

Grab the Full PDF Research Report @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-in-vitro-diagnostics-ivd-market

Critical Insights Related to the In Vitro Diagnostics (IVD) Included in the Report:

• Value chain analysis of prominent players in the market

• Current trends influencing the dynamics of this market across various geographies

• Recent mergers, acquisitions, collaborations, and partnerships

• Revenue growth of this industry over the forecast period

• Marketing strategy study and growth trends

• Growth driven factor analysis

• Emerging recess segments and region-wise market

• An empirical evaluation of the curve of this market

• Ancient, Present, and Probable scope of the market from both prospect value and volume

In Vitro Diagnostics (IVD) Market Dynamics

• Increasing awareness of medicine

Rising awareness of customised medicine and expanding use of point-of-care testing are two other main reasons propelling the in vitro diagnostics/IVD market, among others. Fully automated devices and laboratory automation are also important aspects accelerating market expansion.

• The rise in the importance of companion diagnostics

In addition, the market for in vitro diagnostics and IVDs will see increased growth possibilities in emerging nations, a rise in the importance of companion diagnostics, and a rise in condition-specific markers and tests over the anticipated period of 2022–2029.

• A rise in the Infectious disease

The rise in the prevalence of chronic and infectious diseases is a primary factor driving the IVD market’s expansion. Chronic diseases like diabetes, cancer, cardiovascular disease, and tuberculosis are becoming more common in the contemporary business environment. Additionally, there has been a marked increase in the number of individuals with infectious disorders such STDs, respiratory illnesses, and gastrointestinal conditions (sexually transmitted diseases). The market for IVDs is driven by the demand for diagnostic tools, which is anticipated to rise as these diseases become more prevalent.

Restraints/Challenges

In vitro diagnostics/IVD market growth in the forecast period will be further hampered by changing regulatory environments and rising operational barriers associated with performing diagnostic tests. However, increasing unfavourable reimbursement scenarios and constant government regulation updates are the main factors among others that will restrain the market growth.

Get a Detailed Summary of the Research Report @ https://www.databridgemarketresearch.com/reports/global-in-vitro-diagnostics-ivd-market

Market Regional Analysis/Insights

The in vitro diagnostics (IVD) market is analysed and market size insights and trends are provided by country, technique, application, end-user and product and service as referenced above.

The countries covered in the in vitro diagnostics (IVD) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, and Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the in vitro diagnostics (IVD) market due to rising favourable government regulations, well-established diagnostic infrastructure.

Asia-Pacific is the expected region in terms of growth in vitro diagnostics (IVD) market due to rising presence of a large number of target populations along with improving healthcare infrastructure in this region.

In Vitro Diagnostics (IVD) Market Scope

By Technique

• In vitro diagnostics (IVD)

By Application

• Gastrointestinal Diseases

By End-User

By Product and Service

Table of Content:

Section 01: Executive Summary

Section 02: Scope of The Report

Section 03: Research Methodology

Section 04: Introduction

Section 05: Market Landscape

Section 06: Market Sizing

Section 07: Five Forces Analysis

Section 08: Market Segmentation by Technique

Section 09: Market Segmentation by Application

Section 10: Customer Landscape

Section 11: Market Segmentation by End-User

Section 12: Regional Landscape

Section 13: Decision Framework

Section 14: Drivers and Challenges

Section 15: Market Trends

Section 16: Competitive Landscape

Section 17: Company Profiles

Section 18: Appendix

For More Insights Grab TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-molecular-diagnostics-market

Browse Trending Reports:

• Immuno In-Vitro Diagnostics (IVD) Market, ByProduct Type (Reagents, Instruments,  Data Management Software, Services), Immunodiagnostics Technique (Enzyme-Linked Immunosorbent Assay, Rapid Tests, Enzyme-Linked ImmunoSpot Assays, Radioimmunoassay, Western Blotting),  Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Drug Testing/Pharmacogenomics, HIV/AIDS, Autoimmune Diseases, Nephrology, Others), End User (Hospital Laboratories,  Clinical Laboratories, Point Of Care Testing, Patient Self-Testing, Academic Institutes, Others),Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-immuno-ivd-market

• IVD Regulatory Affairs Outsourcing Market, By Service (Regulatory Writing & Submissions, Regulatory Registration & Clinical Trial Applications, Regulatory Consulting, Legal Representation, Data Management Services, Chemistry Manufacturing and Controls (CMC) Services, and Others), Indication (Oncology, Neurology, Cardiology, Clinical Chemistry and Immunoassays, Precision Medicine, Infectious Diseases, Diabetes, Genetic Testing, HIV/AIDS, Haematology, Drug Testing/Pharmacogenomics, Blood Transfusion, Point of Care, and Others), Deployment Mode (Cloud and On-Premises), Organization Size (Small and Medium Enterprises (SMES) and Large Enterprises), Stage (Clinical, Preclinical, and PMA (Post-Market Authorization)), Class (Class I, Class II, and Class III), End User (Pharmaceutical Companies, Medical Device Companies, Biotechnology Companies, and Others), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Netherlands, Switzerland, Russia, Turkey, Belgium, Rest of Europe, China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific, Saudi Arabia, South Africa, U.A.E., Egypt, Israel and Rest of Middle East and Africa, Brazil, Argentina, & Rest of South America) https://www.databridgemarketresearch.com/reports/global-ivd-regulatory-affairs-outsourcing-market

• North America IVD Regulatory Affairs Outsourcing Market, By Service (Regulatory Writing & Submissions, Regulatory Registration & Clinical Trial Applications, Regulatory Consulting, Legal Representation, Data Management Services, Chemistry Manufacturing and Controls (CMC) Services, and Others), Indication (Oncology, Neurology, Cardiology, Clinical Chemistry and Immunoassays, Precision Medicine, Infectious Diseases, Diabetes, Genetic Testing, HIV/AIDS, Haematology, Drug Testing/Pharmacogenomics, Blood Transfusion, Point of Care, and Others), Deployment Mode (Cloud and On-Premises), Organization Size (Small and Medium Enterprises (SMES) and Large Enterprises), Stage (Clinical, Preclinical, and PMA (Post-Market Authorization)), Class (Class I, Class II, and Class III), End User (Pharmaceutical Companies, Medical Device Companies, Biotechnology Companies, and Others), Country (U.S., Canada, Mexico) https://www.databridgemarketresearch.com/reports/north-america-ivd-regulatory-affairs-outsourcing-market

• Europe IVD Regulatory Affairs Outsourcing Market, By Service (Regulatory Writing & Submissions, Regulatory Registration & Clinical Trial Applications, Regulatory Consulting, Legal Representation, Data Management Services, Chemistry Manufacturing and Controls (CMC) Services, and Others), Indication (Oncology, Neurology, Cardiology, Clinical Chemistry and Immunoassays, Precision Medicine, Infectious Diseases, Diabetes, Genetic Testing, HIV/AIDS, Haematology, Drug Testing/Pharmacogenomics, Blood Transfusion, Point of Care, and Others), Deployment Mode (Cloud and On-Premises), Organization Size (Small and Medium Enterprises (SMES) and Large Enterprises), Stage (Clinical, Preclinical, and PMA (Post-Market Authorization)), Class (Class I, Class II, and Class III), End User (Pharmaceutical Companies, Medical Device Companies, Biotechnology Companies, and Others), Country (Germany, France, U.K., Italy, Spain, Netherlands, Switzerland, Russia, Turkey, Belgium & Rest of Europe) https://www.databridgemarketresearch.com/reports/europe-ivd-regulatory-affairs-outsourcing-market

• Allergy Diagnostics Market, By Service (Assay Kits, Instruments, Services, Consumables), Tests (In-vivo Tests, In-vitro Tests), Allergen (Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens), End-User (Diagnostic Laboratories, Hospital-Based Laboratories, Academic Research Institutes, Other End Users)-Industry Trends and Forecast to 2029. https://www.databridgemarketresearch.com/reports/global-allergy-diagnostics-market

• Molecular Diagnostics Market, By Products (Reagents and Kits, Instruments, Services and Software), Technology (Mass Spectrometry (MS), Capillary Electrophoresis, Next Generation Sequencing (NGS), Chips And Microarray, Polymerase Chain Reaction (PCR)-Based Methods, Cytogenetics, In Situ Hybridization (ISH or FISH), Molecular Imaging, Others), Application (Oncology, Pharmacogenomics, Microbiology, Prenatal Tests, Tissue Typing, Blood Screening, Cardiovascular Diseases, Neurological Diseases, Infectious Diseases, Others), End User (Hospital, Clinical Laboratories, Academics) – Industry Trends and Forecast to 2029 https://www.databridgemarketresearch.com/reports/global-molecular-diagnostics-market

About Data Bridge Market Research:

An absolute way to forecast what the future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us: –

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: [email protected]